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Snow day!
Sheila A. Stewart, PhD, associate 
professor of cell biology and physiology 
and of medicine, makes her way across 
the Ellen S. Clark Hope Plaza into work 
with son Konner, 6, and daughter Kyra, 
2, in tow. While the kids watched 
movies, Stewart met with laboratory 
colleagues and an invited speaker. This 
late February snowfall that shut down 
schools was eclipsed just one month 
later by a spring snowstorm that left a 
record-breaking one-day snow total of  
12.4 inches in St. Louis.
View enhanced content online:  
outlook.wustl.edu   
Like the School of Medicine on Facebook:  
facebook.com/WUSTLmedicine.health   
Follow us on Twitter: 
www.twitter.com/WUSTLmedschool
Stay connected
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 22  Teamwork
COVER  Jean E. Schaffer, MD,  
directs the Washington University  
Diabetes Research Center (DRC).  
As the DRC celebrates its 36th year  
of National Institutes of Health (NIH) 
funding, its researchers are focusing  
on the myriad complications of diabetes.  
To learn more, please turn to page 16.   
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Match Day!
 8 Graduating medical students learned which residency programs they will enter at the 
annual Match Day ceremony in March.
Seeds of Discovery
 10 e Institute of Clinical and Translational Sciences (ICTS) supports medical research 
that will benet patients quickly.
Diabetes Complications   
 16 Multidisciplinary researchers study the  body-wide complications of diabetes at  
the Diabetes Research Center. 
Now We’re Talking  
 22 Students from across the medical center come together to learn teamwork skills  
that will serve them well in their careers.
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hat can we learn about human 
evolution from an eel-like 
creature with a sucker-shaped 
mouth? Apparently, quite a lot.
A large team of scientists has decoded 
the genome of a sea lamprey — one of the 
few ancient, jawless species of vertebrates 
that has survived through the modern era.
The findings were detailed Feb. 24 in 
Nature Genetics.
Lampreys diverged from our own lin-
eage about 500 million years ago, during 
the Cambrian period. The new research 
sheds light on how the species — long 
considered an invasive predator — adapted 
and thrived over the ages. Analyzing its 
genome will provide scientists with insights 
into the evolution of organisms as diverse 
as frogs, chickens and humans, all of which 
have backbones.
“The lamprey genome is unique in that 
it has characteristics of vertebrates but it 
also carries evidence of earlier lineages,” 
says study co-author Wesley C. Warren, PhD, 
research associate professor of genetics at 
the The Genome Institute at Washington 
University. “Decoding this genome is pro-
viding us with unique insight into the origin 
and evolution of all vertebrates.”
Based on fossil records, the Cambrian 
period is noted as a time when living organ-
isms exploded from single-celled structures 
to complex, multicelled life forms. During 
this era, many species developed jaws and 
a skeletal frame that protected the brain, 
spine and nervous system. Some, in fact, 
even developed brains that share some of 
the same basic structures and functions as 
the brains of modern humans.
For example, Warren and his colleagues 
at the University of Kentucky and Michigan 
State were surprised to discover genes in the 
lamprey genome that direct the production 
of myelin, the fatty sheath that insulates 
nerve fibers and is needed for nerve signals 
to move from the brain down the spinal cord 
and into the extremities.
By mapping the sea lamprey genome,  
scientists hope to uncover more details 
about how and when humans evolved. 
Future studies also could pinpoint when 
people evolved jaws, arms and legs and an 
adaptive immune system.
Understanding the sea lamprey’s genetic 
makeup also may lead to ways to limit their 
destruction of aquatic life. The invasive spe-
cies feeds by attaching its sucker-shaped 
mouth to the skin of other fish, including 
salmon and trout, and burrowing its sharp 
tongue and teeth into its prey. One sea lam-
prey can kill more than 40 pounds of fish in 
its lifetime, and the U.S. and Canadian gov-
ernments spend $10 million to $15 million 
annually to control them in the Great Lakes.
Ancient sea lamprey offers insight into origin of vertebrates
Mapping a living relic
Decoding the lamprey 
genome is providing 
scientists with unique 
insight into the origin and 
evolution of all vertebrates.
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Children with traumatic brain injuries are more likely to 
survive and avoid long-term disabilities when treated aggres-
sively as part of a designated neurocritical care program that 
brings together neurologists, neurosurgeons, trauma and 
other critical care specialists, according to a new study at 
Washington University School of Medicine.
e investigators tracked the results of such a program at 
St. Louis Children’s Hospital. ey studied the outcome of 
123 cases before and aer the hospital launched a pediatric 
neurocritical care program (PNCP) in September 2005.
“We were amazed by the results,” says Jose A. Pineda, MD, 
assistant professor of pediatrics and neurology, and director 
of the program at St. Louis Children’s. “We analyzed the 
data rigorously, and we found that our new program of care 
resulted in a striking improvement in outcome for children 
with severe traumatic brain injury. Mortality for these chil-
dren was dramatically reduced, and we also noted a mean-
ingful improvement in outcomes for survivors. We know 
that children who suer traumatic brain injuries have long 
lives ahead and must reintegrate into society and be inde-
pendent. at’s where we set the bar.”
e ndings are available online in the journal e Lancet 
Neurology. e study was led by Pineda, neurosurgeon 
Jerey R. Leonard, MD, and  
pediatric intensivist Allan Doctor, 
MD, chief of pediatric critical 
care at St. Louis Children’s.
e program’s aggressive 
approach to treating head injuries 
suered in car, bicycle, sports-
related and other such accidents 
targets secondary damage, espe-
cially damage provoked by dan-
gerous increases in intracranial pressure. 
Now that there is proof that PNCPs do make a signicant 
dierence, Pineda and his fellow researchers have two key 
goals: to sustain the outcomes they’ve seen since the pro-
gram was created at St. Louis Children’s, and to spur other 
institutions to implement their own such programs.
Pineda credits the success of the program in large part to 
a close relationship with colleagues in neurosurgery, neurol-
ogy, trauma surgery and radiology and other team members.
“We developed this collaborative, highly choreographed 
clinical pathway aer rst forging a partnership in caring for 
individual cases together,” says Pineda. “It’s incredibly 
rewarding to see synergy emerge aer bringing our teams 
together to form the PNCP.”
Student favorites   Gregory M. Polites, MD, and Steven 
C. Cheng, MD, share the spotlight at the annual  Distinguished Service 
Teaching Awards ceremony. Polites, associate professor of emergency 
medicine, was presented with the Course Master of the Year Award by 
the Class of 2015; Cheng, assistant professor of medicine, was given 
the Professor of the Year Award by the Class of 2014.  For a full list of 
awardees at the event, please visit news.wustl.edu.
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Rao receives prize for vision proposal
A Washington University retina specialist is one of 10 U.S. 
scientists selected by the National Eye Institute (NEI), part  
of the National Institutes of Health (NIH), for innovative 
projects to improve or restore vision.
e winning proposal from Rajesh C. Rao, MD, a vitreo-
retinal surgery fellow in the Department of Ophthalmology 
and Visual Sciences, was chosen from nearly 500 entries.  
Rao was one of two retina clinicians 
to receive the award and the youngest 
winner in the national competition.
His proposal involves restoring 
vision in patients whose retinas have 
deteriorated from diseases like age-
related macular degeneration, the 
leading cause of vision loss in adults.
Rao wants to reprogram skin and 
blood cells from patients because they 
can be easy to isolate and are compat-
ible with the immune system. Once 
reprogrammed, those cells could 
be transplanted into the retina, the 
structure at the back of the eye that 
converts light into vision.
“We want to use gene therapy and other techniques to 
repair the damage that occurs in degenerative retinal dis-
eases,” says Rao. “By identifying the small molecules that 
directly convert a mature cell into a retinal cell, we hope to 
reprogram cells that already exist in the body to make them 
useful in preserving or restoring vision.”
Pediatric brain injury program 
saves lives, reduces disabilities
Collaborative team improves outcomes
Rajesh C. Rao, MD
  
The study is the first to 
show the benefits of a 
pediatric neurocritical care 
program and an aggressive 
approach to treating brain 
injuries in children.
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e Human Connectome Project, a ve-year endeavor to 
link brain connectivity to human behavior, has released a set 
of high-quality imaging and behavioral data to the scientic 
community. e project has two major goals: to collect vast 
amounts of data using advanced brain imaging methods on  
a large population of healthy adults, and to make the data 
freely available so that scientists worldwide can make further 
discoveries about brain circuitry. 
e initial data release includes brain imaging scans plus 
behavioral information — individual dierences in person-
ality, cognitive capabilities, emotional characteristics and 
perceptual function — obtained from 68 healthy adult vol-
unteers. Over the next several years, the number of subjects 
studied will increase steadily to a nal target of 1,200. e 
initial release is an important milestone because the new 
data have much higher resolution in space and time than 
data obtained by conventional brain scans.
e Human Connectome Project (HCP) consortium is led 
by David C. Van Essen, PhD, Alumni Endowed Professor, 
and Kamil Ugurbil, PhD, Director of the Center for Magnetic 
Resonance Research and the McKnight Presidential Endowed 
Chair Professor at the University of Minnesota. 
“By making this unique 
data set available now, and 
continuing with regular 
data releases every quarter, 
the Human Connectome 
Project is enabling the 
scientic community to 
immediately begin explor-
ing relationships between 
brain circuits and indi-
vidual behavior,” says Van 
Essen. “e HCP will have a 
major impact on our under-
standing of the healthy 
adult human brain, and it 
will set the stage for future projects that examine changes in 
brain circuits underlying the wide variety of brain disorders 
aicting humankind.”
e consortium includes more than 100 investigators 
and technical sta at 10 institutions in the United States 
and Europe. It is funded by 16 components of the National 
Institutes of Health via the Blueprint for Neuroscience 
Research (neuroscienceblueprint.nih.gov).
e imaging data set released by the HCP takes up about 
two terabytes (2 trillion bytes) of computer memory.
Human Connectome Project 
releases brain connectivity data 
WUSM co-leads international consortium
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Physicians from the Alvin J. Siteman Cancer Center at 
Barnes-Jewish Hospital and Washington University School of 
Medicine began seeing patients in January at Siteman’s newest 
outpatient location in south St. Louis County.
Located at Interstate 55 and Butler Hill Road, Siteman 
Cancer Center–South County oers access to the same 
advanced treatments and technology available at Siteman’s 
main location at Washington University Medical Center.
“Treatment at a top 10 U.S. cancer center just got easier 
for hundreds of thousands of area residents,” says Timothy J.  
Eberlein, MD, Siteman’s director. 
“Along with convenience,  
patients at the new location will 
benet from the world-class cancer 
care and outstanding research of our 
Washington University physicians.”
Multidisciplinary care provided 
by radiation oncologists, medical 
oncologists and surgeons will allow 
patients to see as many as three physicians in one trip. is 
team approach also means a patient’s treatment plan can be 
determined in one visit.
Bruce J. Roth, MD, professor of medicine, is director of 
medical oncology at the new location, and Parag J. Parikh, 
MD, assistant professor of radiation oncology, is director of 
radiation oncology.
Siteman’s two other satellite locations are in Creve Coeur 
at Barnes-Jewish West County Hospital and in St. Charles 
County at Barnes-Jewish St. Peters Hospital. Appointments 
for any of the sites may be made by calling 314-747-7222 or 
toll-free 800-600-3606 from 8 am to 4:30 pm CDT weekdays. 
Siteman south county location open
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New text goes here
 
World-class cancer care  
at a top 10 U.S. cancer  
center “just got easier”  
for hundreds of thousands 
of St. Louis area residents.
humanconnectome.org
Caregivers unite   Brittany Perez, a graduating student 
in the Program in Occupational Therapy, explains the proper way to 
move a patient who has a Foley catheter in place. At a recent inter-
disciplinary learning event, Washington University occupational 
therapy students and nursing students from the Goldfarb School of 
Nursing at Barnes-Jewish College shared their knowledge. The two 
groups practiced the proper use of hospital equipment and skills — 
including patient transfers — vital to caring for patients.
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n research that could one day improve 
the success of stem cell transplants and 
chemotherapy, scientists have found 
that distinct niches exist in bone marrow to 
nurture different types of blood stem cells. 
Stem cells in the blood are the precur-
sors to infection-fighting white blood cells 
and oxygen-carrying red blood cells. 
The research, by a team at the School 
of Medicine, was reported Feb. 24 in the 
advance online edition of Nature.
The new findings, in mice, suggest that 
it may be possible to therapeutically target 
support cells in a particular niche.
On the one hand, a drug that nour-
ishes support cells could encourage blood 
stem cells to establish themselves in the 
bone marrow, enabling patients who have 
had stem cell transplants to more quickly 
rebuild their immune systems. 
On the other, tumor cells are known to 
hide in the bone marrow, and a drug that 
disrupts the niche environment may drive 
cancer cells into the bloodstream, where 
they are more vulnerable to the damaging 
Targeting stem cells to build immunity
I
M E D I C I N E
effects of chemotherapy. 
“Our results offer hope for targeting 
these niches to treat specific cancers or 
to improve the success of stem cell trans-
plants,” says senior author Daniel C. Link, 
MD, the Alan A. and Edith L. Wolff Professor 
of Medicine. “Already, we and others are 
leading clinical trials to evaluate whether it 
is possible to disrupt these niches in patients 
with leukemia or multiple myeloma.” 
In a phase II pilot study led by medical 
oncologist Geoffrey L. Uy, MD, assistant  
professor of medicine, Link is evaluating  
whether the drug G-CSF can alter the stem 
cell niche in patients with acute lympho-
blastic leukemia whose cancer has recurred 
or is resistant to treatment.
While it’s too early to know whether 
the treatment approach will be successful, 
Link’s new research in mice is bolstered by 
a companion paper in the same issue of 
Nature. In that research, Sean J. Morrison, 
PhD, director of the Children’s Medical 
Center Research Institute at the University 
of Texas Southwestern Medical Center in 
Dallas, used similar molecular methods to 
also discover distinct niches in the bone 
marrow for blood stem cells. 
“There’s a lot of interest right now in  
trying to understand these niches,” Link 
adds. “Both of these studies add new  
information that will be important as we 
move forward.”
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New digs    Patients of Shriners Hospital  
for Children and representatives from Shriners  
and Washington University Medical Center  
(including medical school Dean Larry J. Shapiro, 
MD, sixth from right) broke ground March 20 on a  
$50 million hospital on the medical center campus.  
The planned facility, located at the corner of 
Clayton and Newstead avenues, will replace the 
50-year-old Shriners Hospital in Frontenac.  
Inset: Shriner Ambassador Freddie J. Hanewinkel 
holds the cast he wore as a baby during treatment 
at Shriners Hospital for Children.
Distinct niches exist in bone marrow to nurture different 
types of blood stem cells. In mice bone marrow, blood 
stem cells, highlighted in blue, are nurtured by support 
cells shown in red and yellow.
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Four School of Medicine faculty members have been named 
fellows of the American Association for the Advancement of 
Science (AAAS), the world’s largest general scientic society.
e newest fellows are Alison Goate, PhD, Jeanne M. 
Nerbonne, PhD, D.C. Rao, PhD, and Barry Sleckman, MD, 
PhD. Members are given the rank of fellow, the highest 
honor awarded by AAAS, by their peers in recognition of 
scientically or socially distinguished eorts to advance  
science or its applications.
Goate, the Samuel and Mae S. Ludwig Professor of 
Genetics in Psychiatry and director of the Hope Center 
for Neurological Disorders at the School of Medicine, was 
praised by colleagues for her work in the genetics of neuro-
psychiatric disease, particularly Alzheimer’s disease. She  
also studies genetic risk for 
substance dependence.
Nerbonne, the Alumni 
Endowed Professor of 
Molecular Biology and 
Pharmacology, was lauded 
by colleagues for her con-
tributions to research and 
training in the molecular 
and cell biology of ion 
channels that control 
excitability in the car-
diovascular and nervous 
systems. Nerbonne also 
leads the Translational 
Cardiovascular Biobank and Repository (TCBR), funded in 
part by the Children’s Discovery Institute and Washington 
University’s Institute of Clinical and Translational Sciences 
(ICTS), a resource for investigators interested in studying 
heart and vascular conditions in adults and children.
Rao, director of the Division of Biostatistics, was honored 
by colleagues for his contributions in the area of genetic  
epidemiology and human genetics, and for his work in train-
ing the next generation of statisticians and epidemiologists. 
Sleckman, the Conan Professor of Pathology and 
Immunology, was lauded by peers for his work in the eld  
of immunology and biochemistry, particularly for his  
pioneering research into how cells repair breaks in their 
DNA and how problems in these repair processes can  
contribute to cancer.
ese School of Medicine faculty members were among 
702 new fellows acknowledged in the Nov. 30 issue of  
Science magazine.
Four  medical school faculty  
honored as AAAS fellows
Distinguished efforts advance science
Robert P. Mecham, PhD, has been named interim head of the 
Department of Cell Biology and Physiology. 
Mecham, the Alumni-Endowed Professor of Cell Biology 
and Physiology, replaces Helen Piwnica-Worms, PhD,  
the Gerty T. Cori Professor, who has been named vice 
provost, science, at the University of Texas MD Anderson 
Cancer Center.
“Bob won the School of 
Medicine’s distinguished Carl and 
Gerty Cori Faculty Achievement 
Award last year for his pioneering 
research into the structures that join 
cells into tissues and organs,” says 
Larry J. Shapiro, MD, executive vice 
chancellor for medical aairs and 
dean of the School of Medicine. “He 
has been a valued member of the 
faculty since 1977, and I have every 
condence in his ability to lead the 
department through this transition.”
Mecham focuses most of his research on the extracel-
lular matrix, or the structures between cells that join them 
together to form tissues and organs.
He was vice chairman of the Executive Committee of the 
Faculty Council from 2002–03 and served as chairperson of 
the Curriculum Evaluation Committee. He also is a member 
of several university-wide committees.
A three-time winner of the university’s Distinguished 
Teacher Award, Mecham has been extensively involved in 
medical and graduate school instruction. In 2012, he received 
the Carl and Gerty Cori Faculty Achievement Award.
Mecham serves as interim head
Photo ops   Vivian Elgin, shown here with the photo and 
poster she created as part of Photovoice, a project in which partici-
pants document the people, places and things that make up their 
daily lives. Supported by the National Institutes of Health (NIH), the 
project is meant to serve as a conversation starter about the impor-
tance of cancer screening. Elgin’s work was part of a recent exhibi-
tion hosted by the Alvin J. Siteman Cancer Center’s Program for the 
Elimination of Cancer Disparities.
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Robert P. Mecham, PhD
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survey of tanning salon operators 
in Missouri shows that 65 percent 
would allow children as young 
as 10 to 12 years old to use tanning beds. 
That’s despite evidence that any tanning 
bed use increases the risk of all skin cancers, 
including melanoma, the deadliest form of 
skin cancer, later in life.
The survey, part of a study led by  
dermatologists at the School of Medicine, 
also found that many tanning salon 
employees across the state said indoor  
tanning had no associated risks or would 
prevent future sunburns — both false 
claims, according to the study’s authors.
Missouri is one of  
17 states that has no 
minimum age restrictions 
on tanning bed use and 
does not require parental 
consent.
“This should serve as 
a wake-up call for parents 
in Missouri and other 
states that don’t regulate 
tanning beds,” says study co-author Lynn 
A. Cornelius, MD, chief of the Division of 
Dermatology and the Winfred A. and Emma 
R. Showman Professor in Dermatology. 
“With the absence of logical age restric-
tions, we are failing to protect our children, 
who are at an increased risk of developing 
skin cancer when exposed to the high-
intensity levels of ultraviolet light that can 
be received in a tanning bed.”
The findings appeared online Feb. 25  
in Pediatrics.
Exposure to ultraviolet light from  
tanning beds makes users 75 percent 
more likely to develop melanoma than 
nonusers, and some studies have reported 
an increased risk of up to three times, 
Cornelius says. They’re also up to 2.5 times 
Shining a light
A
D E R M A T O L O G Y
more likely to develop more common  
nonmelanoma skin cancers, such as basal 
cell and squamous cell cancers.
Of the states that regulate tanning bed 
use, some ban minors until they reach a 
certain age; others require parental permis-
sion. Last year, California became the first 
state to prohibit the use of indoor tanning 
beds by anyone younger than 18.
Cornelius says she and her colleagues 
at the Alvin J. Siteman Cancer Center at 
Barnes-Jewish Hospital and Washington 
University School of Medicine routinely see 
young, typically female, melanoma patients 
who report previous tanning bed use.
“Indoor tanning may 
seem innocuous at first,” 
she says. “Due to what is 
called ‘tumor lag time,’ 
or the time between an 
exposure to a carcinogen 
such as ultraviolet and the 
development of a cancer,  
it may take a decade or 
longer for someone who 
has been exposed to artificial ultraviolet 
radiation to develop a skin cancer.”
For the study, the researchers identified 
831 indoor tanning facilities across Missouri 
and randomly selected and called 375 of 
them, posing as prospective clients. For 
consistency, the researchers made attempts 
to survey each salon twice.
“Minimizing exposure to ultraviolet 
rays, no matter the source, lowers one’s 
risk of skin cancer,” says Graham A. Colditz, 
MD, PhD, a cancer prevention expert at 
Washington University and the Siteman 
Cancer Center who wasn’t involved in the 
study. “The problem with indoor tanning is 
that users start very young and, unlike the 
sun, tanning beds are a completely avoid-
able cancer risk.”
Do tanning facilities communicate the risks to preteens?
65 %  would accept pre-teens
No one under the age of 18  
should do indoor tanning
Seek medical advice and get a  
skin assessment before tanning
Tanning facilities should post 
warnings about health risks
43%  claim there are no risks
80%  say it prevents sunburns
What Missouri tanning facilities  
said in a recent survey
* Guidelines endorsed by the World Health Organization  
and the U.S. Food and Drug Administration
Outlook  7
Health recommendations  
regarding indoor tanning*
 
Ultraviolet rays from the 
sun and artificial tanning 
devices are carcinogenic 
to humans, equivalent to 
tobacco.  —  International 
Agency for Research on Cancer
131511_Pulse_1-7_cs6.indd  7 4/24/13  12:52 PM
matchday
MATCH DAY WAS HELD MARCH 15, 2013,   and 120 graduating medical students   learned their match results from  
the National Resident Matching Program. 
During the annual ceremony, senior medical  
students in the United States learn which  
residency programs they will enter.  
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A L A B A M A
Birmingham
University of Alabama  
Medical Center 
I N T E R N A L  M E D I C I N E
Jori Ellen May
C A L I F O R N I A
Los Angeles
Harbor-UCLA Medical Center 
D I A G N O S T I C  R A D I O L O G Y
Gregory Randal Bryant  
Oakland
Kaiser Permanente Medical Group
I N T E R N A L  M E D I C I N E
Somalee Banerjee
San Diego
Navy Medical Center
P E D I AT R I C S
Tammy Sue Shirley
University of California- 
San Diego Medical Center
I N T E R N A L  M E D I C I N E
Adam M. Greenbaum  
O B S T E T R I C S A N D G Y N E CO LO G Y
Sarah Campbell Proehl
Amanda Michelle Stewart
O P H T H A L M O LO G Y
Courtney Lynne Ondeck
P E D I AT R I C S
YunZu Michele Wang
San Francisco
California Pacific Medical Center
I N T E R N A L  M E D I C I N E
Laura Alycia Battle
University of California- 
San Francisco
D I A G N O S T I C  R A D I O L O G Y
Jason W. Curtis
FA M I LY  M E D I C I N E
Ignacio Becerra-Licha 
I N T E R N A L  M E D I C I N E
Brian David Muegge
Stanford
Stanford University Program
I N T E R N A L  M E D I C I N E
Jerey Scott Ketchersid
O B S T E T R I C S A N D G Y N E CO LO G Y
Sanaa Hasan Suharwardy
P S Y C H I AT R Y  R E S E A R C H
George Mark Freeman Jr.
C O L O R A D O
Denver
University of Colorado 
D E R M AT O L O G Y
David Richard Pearson
Fort Collins
Fort Collins Family  
Medical Program 
FA M I LY  M E D I C I N E
Bethany Amber Davis
C O N N E C T I C U T
Hartford
University of Connecticut  
School of Medicine
E M E R G E N C Y  M E D I C I N E
Tina H. Chen
New Haven
Yale-New Haven Medical Center
D E R M AT O L O G Y
Matthew David Vesely
I N T E R N A L  M E D I C I N E
Erica Paige Young
O P H T H A L M O LO G Y
Alexander ien An 
Nguyen
D I S T R I C T  O F 
C O L U M B I A
Washington
Georgetown University Hospital
R A D I AT I O N  O N C O L O G Y
Ima Paydar 
F L O R I D A
Miami
Jackson Memorial Hospital 
I N T E R N A L  M E D I C I N E
David Qianli Ying
G E O R G I A
Atlanta
Emory University  
School of Medicine 
E M E R G E N C Y  M E D I C I N E
Elizabeth Davlantes
H A W A I I
Honolulu
University of Hawaii 
O R T H O PA E D I C  S U R G E R Y 
R E S E A R C H
Nicholas Christian Foeger
I L L I N O I S
Chicago 
McGaw Medical Center of  
Northwestern University 
I N T E R N A L  M E D I C I N E
Christopher James Adkins
Nicole K. Cibulka
P H Y S I C A L  M E D I C I N E  A N D 
R E H A B I L I TAT I O N
Abby Ling-Lee Stephens
University of Illinois
G E N E R A L  S U R G E R Y
Guillermo Javier Ares
I N D I A N A
Indianapolis
Indiana University  
School of Medicine 
E M E R G E N C Y  M E D I C I N E
Daniel Nathan Seitz
I O W A
Iowa City
University of Iowa  
Hospitals and Clinics 
D E R M AT O L O G Y
Nicholas Michael  
  Bontumasi
E M E R G E N C Y  M E D I C I N E
Luke Michaud Lowry
M A S S A C H U S E T T S
Boston
Beth Israel Deaconess Hospital
D I A G N O S T I C  R A D I O L O G Y 
Jerey Nelson Dines
Brigham and Women’s Hospital
I N T E R N A L  M E D I C I N E  P R I M A R Y 
Michelle Amanda  
  Jose-Kampfner
PAT H O L O G Y 
Isaac H.S. Solomon  
Children’s Hospital
P E D I AT R I C S
Matthew Raymond Vogt
P E D I AT R I C S  U R B A N  
H E A LT H  A D V O C A C Y
Kristen Suzanne Grant 
Massachusetts General Hospital 
PAT H O L O G Y
Kwadwo Asare Oduro Jr. 
M I C H I G A N
Ann Arbor
University of Michigan Hospitals
A N E S T H E S I O L O G Y 
Hank Haw Sun
I N T E R N A L  M E D I C I N E 
Jared Daniel Wilkinson
M I S S O U R I
Kansas City
University of Missouri-Kansas City 
O B S T E T R I C S A N D G Y N E CO LO G Y
Jennifer Ann Reeves
St. Louis
Barnes-Jewish Hospital 
A N E S T H E S I O L O G Y
Amrita Aranake
Lara Wiley Crock
D E R M AT O L O G Y
Emily Michelle Beck
William Howard McCoy IV 
D I A G N O S T I C  R A D I O L O G Y
Amirali Modir Shanechi
Kevin Andrew Neal
Erin Kerr Romberg
E M E R G E N C Y  M E D I C I N E
Christopher William  
  Arvind Lawrence
G E N E R A L  S U R G E R Y
Leisha Carol Elmore
Matthew Robert Schill
Tara Rachelle Skebba
Wen Hui Tan
I N T E R N A L  M E D I C I N E
Bahaa Ahmad Bedair
Stacy Zhao Dai
Patricia Elizabeth Litkowski
Aaron Joseph Mintz
Nathan Herling Moore
Chelsea Elizabeth Pearson 
N E U R O L O G I C A L  S U R G E R Y
Santoshi Shalini Indrakanti 
School of Medicine graduates are highly  
successful in obtaining competitive training  
programs. In 2013, 34 percent of the graduating 
class selected a primary care eld and 24 percent  
matched into highly competitive specialties, 
including dermatology, ophthalmology, surgery, 
urology, orthopaedic surgery and otolaryngology.
Moving forward
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O B S T E T R I C S A N D G Y N E CO LO G Y
Antonina I. Frolova
Jennifer Lee Troyer
Morgan Bernard Wolfe Jr.
O R T H O PA E D I C  S U R G E R Y
Christopher Luke  
  Stockburger
Robert David Wojahn
O T O L A R Y N G O LO G Y 
Tzyy-Nong Tina Liou 
P S Y C H I AT R Y 
Andrea Marie  
  Giedinghagen
Tarik Hadzic
Agnieszka Monika  
  Milczarek
Carrie Laub Morris
Alecia Cristen  
  Vogel-Hammen
R A D I AT I O N  O N C O L O G Y 
Yuan James Rao 
St. Louis Children’s Hospital
CHILD NEUROLOGY
Amelia Glatha Drace
P E D I AT R I C S
Jeery C. Hoover
June Yueheng Hu
Margaret Ashley Young
Saint Louis University  
School of Medicine
FA M I LY  M E D I C I N E
Betsy Peixi Wan
O R T H O PA E D I C  S U R G E R Y
Ugochi C. Okoroafor
N E B R A S K A
Omaha
University of Nebraska  
Affiliated Hospitals
R A D I AT I O N  O N C O L O G Y
Vivek Verma
N E W  H A M P S H I R E
Lebanon
Dartmouth-Hitchcock  
Medical Center 
D E R M AT O L O G Y
Mackenzie Capshaw Asel
N E W  M E X I C O
Albuquerque
University of New Mexico 
I N T E R N A L  M E D I C I N E
Tracy Marsh Carlson
N E W  Y O R K
New York
Einstein-Montefiore 
Medical Center
O B S T E T R I C S A N D G Y N E CO LO G Y
Mengyang Sun
Icahn School of Medicine at 
Mt. Sinai
P S Y C H I AT R Y 
Kara Jill Gulewicz 
New York Presbyterian Hospital-
Columbia
A N E S T H E S I O L O G Y
Kurt Joseph Homeister
Dorothy van Oppen 
New York Presbyterian Hospital-
Columbia and Cornell
O T O L A R Y N G O LO G Y
Kenny Fei Lin 
New York University  
School of Medicine
R A D I AT I O N  O N C O L O G Y
Raymond Bernard Mailhot
St. Luke’s-Roosevelt Hospital
G E N E R A L  S U R G E R Y 
Amy Margaret Liang
N O R T H  C A R O L I N A
Durham
Duke University
O P H T H A L M O L O G Y
Andrew Robert Lee
O H I O
Cincinnati
Cincinnati Children’s Hospital
P E D I AT R I C S
Kristen Marie Danley
University Hospital
E M E R G E N C Y  M E D I C I N E
Charles Elwood Kircher
Matthew Kevin Riddle
Cleveland
Case Western Reserve University
O P H T H A L M O L O G Y
Musa Raed Abdelaziz
Columbus
Ohio State University  
Medical Center
A N E S T H E S I O L O G Y
Douglas James Dearth Jr.
O R E G O N
Portland
Oregon Health & Science 
University
E M E R G E N C Y  M E D I C I N E
Ran Ran
P E N N S Y L V A N I A
Philadelphia
Children’s Hospital
P E D I AT R I C S
Jie Tang
Fox Chase Cancer Center
R A D I AT I O N  O N C O L O G Y
Yanqun Dong
Hospital of the University  
of Pennsylvania
I N T E R N A L  M E D I C I N E
Nicole Samantha Maloney
P S Y C H I AT R Y
Puneet Kaur Chawla Sahota
St. Christopher’s Hospital  
for Children
P E D I AT R I C S  P R E L I M I N A R Y
Colleen Helen Cotton
Thomas Jefferson University 
Program
O R T H O PA E D I C  S U R G E R Y
Eric Michael Padegimas
Pittsburgh
University of Pittsburgh  
Medical Center
D E R M AT O L O G Y
Kristin Page Bibee
O R T H O PA E D I C  S U R G E R Y 
R E S E A R C H
Rashmi Agarwal
T E N N E S S E E
Nashville
Vanderbilt University  
Medical Center
I N T E R N A L  M E D I C I N E
Kathryn Meredith Evans
Catherine N. Le
Mona Mashayekhi
T E X A S
Dallas
University of Texas- 
Southwestern Medical School 
E M E R G E N C Y  M E D I C I N E
Kavita B. Joshi
P E D I AT R I C S
Krista Renee Whitney
U R O LO G Y
Varun Sundaram
Houston
Baylor College of Medicine 
P E D I AT R I C S
Rachel Elizabeth Amthor
Michael Anthony Lee Jr.
P E D I AT R I C S  G LO B A L  H E A LT H
Yi Wang
University of Texas Medical School 
G E N E R A L  S U R G E R Y
Ronald Chang
U T A H
Salt Lake City
University of Utah  
Affiliated Hospitals
C H I L D  N E U R O L O G Y
Jennifer Ann Hranilovich
W A S H I N G T O N
Seattle
University of Washington 
I N T E R N A L  M E D I C I N E
Michelle Catherine Sabo
O B S T E T R I C S A N D G Y N E CO LO G Y
Stephen Andrew McCartney
P S Y C H I AT R Y
Nana-Aba Nduom
W I S C O N S I N
Madison
University of Wisconsin 
O P H T H A L M O L O G Y
Han Kim
C A N A D A
Toronto
University of Toronto 
P L A S T I C  S U R G E R Y
Maryam Saheb-Al-Zamani
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It’s a match! From left: Leisha Elmore; Kathryn Evans and her father, Douglas; and Michael Lee celebrate 2013 Match Day results.
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2007
discovery
seeds of
collaboration
Each dot denotes a faculty member of the 
ICTS, and each connecting line represents a 
collaboration between faculty in submitting 
an NIH grant application. ICTS began in 
2007, above, and by 2010, right, there had 
already been a dramatic increase in the 
number of collaborations and the density of 
interconnections among research groups.
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2010
discovery
funding
initiative speeds
innovation to
improve health
Whether providing pilot funding to  gather initial data or nal funding for projects heading toward publication, grants awarded 
by Washington University’s Institute of Clinical and 
Translational Sciences (ICTS) are ultimately aimed at one 
goal — supporting medical research that has the highest 
likelihood of beneting patients quickly.
“Facilitating new research collaborations across  
traditional disciplinary boundaries is a major goal of 
the ICTS,” says director Bradley A. Evano, MD, MPH, 
assistant dean for clinical and translational research.  
“By doing so, new discoveries can more rapidly be 
translated into prevention, diagnosis and treatment.”
Washington University’s ICTS is one of 60 such programs 
across the country. It is funded through institutional 
resources and through a ve-year, $50 million Clinical and 
Translational Science Award (CTSA) given by the National 
Center for Advancing Translational Sciences of the National 
Institutes of Health (NIH). In its rst six years, the ICTS 
has awarded $6.9 million to 70 projects and, in June 2012, 
its CTSA grant was renewed for an additional ve years.
e ICTS pursues its mission by supporting new research 
infrastructure, funding translational research, training 
young faculty, and facilitating collaborations across 
disciplines. Its research support cores provide expert 
consultation and resources in tissue banking, imaging, 
biostatistics, biomedical informatics, research ethics, 
experimental design, conducting clinical trials, genomic 
analysis, regulatory support and community-engaged 
research. And that’s just the short list.
rough all of these activities, the ICTS is a pillar of 
Washington University’s BioMed 21 initiative, an eort 
dedicated to translating basic science discoveries into 
solutions for the world’s biggest health problems.
“Our researchers work across departmental and  
divisional specialty lines to a greater extent than ever 
before,” says Evano. “We can’t claim credit for all of  
that, but we’ve been one of the forces helping people  
make connections.”
icts.wustl.edu
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O ne example of the school’s connectivity is embodied  in the Women and Infants’ Health Specimen 
Consortium, a program led by Kelle H. Moley, MD,  
co-director of the ICTS and the James P. Crane Professor  
of Obstetrics and Gynecology. 
e consortium was founded in 2007 by 
Moley and Ann M. Gronowski, PhD, associate 
professor of pathology and immunology, with 
the help of an ICTS pilot grant. Investigators 
from a wide range of specialties are involved, 
including pediatrics, microbiology, obstetrics 
and gynecology, pathology, internal medicine 
and developmental biology. 
e purpose of the consortium is to gather 
tissue samples from women before and during 
pregnancy, aer delivery, and from the newborn. 
e tissues collected include cord blood, mater-
nal blood, newborn blood, placenta samples and 
amniotic uid.  
e samples, which are linked to clinical 
reports of the health of the mother and her baby, 
are available to investigators interested in a wide 
array of issues important to women and new-
borns, from repeated pregnancy loss, pre-term 
delivery and pre-eclampsia to endometriosis 
and sexually transmitted diseases. It also may 
provide insights into the origins of childhood 
diseases and the communication that goes on 
between the mother and fetus in utero. 
“is resource allows investigators to have 
access to unique samples that they would not 
normally be able to get on their own,” Moley 
says. “We have about 3,000 patients participating 
in the program and more than 200 patients that 
we have followed throughout the process —  
pre-pregnancy, pregnancy, and aer delivery.”
Moley co-directs the ICTS in part because 
her own research sits at the interface of basic 
research in the laboratory and clinical research that can 
help patients. An expert in reproductive health, her primary 
focus has been endocrine disorders in women, such as those 
related to obesity, diabetes and polycystic ovarian syndrome, 
and their eects on fertility. 
“My work with the ICTS has forced me to think more 
about how my own research can be applied to improve 
health care,” Moley says. “My job is also to ask other basic 
scientists to think about ways that their research can aect 
human health directly and to encourage them to become 
involved with the ICTS.”
mothers’
tissue samples
illuminate
children’s
diseases
Kelle H. Moley, MD
better 
    infant care
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aiming for
consensus in
private
practice
clinical care
Taking medical research into the community and help-ing physicians in private practice is another goal of the 
ICTS. Jane M. Garbutt, MBChB, research associate professor 
of medicine and pediatrics, has been a pioneer in this eort. 
Many times care for common conditions, such as sinus 
infections or pinkeye, diers greatly from one 
doctor to the next. To help determine the best 
solutions for these typical ailments, Garbutt 
established the ICTS-supported Washington 
University Pediatric and Adolescent Ambulatory 
Research Consortium (WUPAARC), a network 
of local pediatricians in private practice who are 
interested in improving clinical care. 
“We try to make our research relevant and 
useful to primary care doctors,” Garbutt says. 
“If you just conduct research studies in aca-
demic institutions, the patients may not be 
representative of the patients going to see their 
regular doctors. If we recruit patients through  
primary care practices, we get more diversity  
in the patient mix.
“And the results will be relevant to other  
doctors with similar practices. e physician 
can look at these studies and say, ‘ese patients 
look similar to mine, so the results should apply 
to them, therefore I will change my practice.’”
Currently, 66 pediatricians and ve nurse 
practitioners from 35 medical practices in the 
St. Louis area participate in WUPAARC. e 
pediatricians themselves suggest the questions 
to be studied by the consortium. 
One ongoing trial is looking at whether  
peer coaching delivered by telephone for  
mothers of children with asthma will help  
better control the disease. Asthma coaches  
help the mother develop a collaborative  
relationship with the child’s doctor and  
provide education and support to encourage 
eective use of asthma medications.
Garbutt’s own research is focused on improving the  
quality of care in the ambulatory setting. She shares her 
expertise in these community-based research methods and 
logistics with other investigators at the university so that 
they might also begin studying ways to improve health  
care in the wider community setting, where so many people 
receive their medical care.  
“e success of any research network is dependent on 
personal relationships,” Garbutt says. “We have to build a 
network that transcends one study. We have to build the 
relationships and structure needed for research and then 
nurture it.”
Randall S. Sterkel, MD, and Jane M. Garbutt, MBChB
into the  
    community
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Along with its commitment to community-based     research, the ICTS also supports work that is done in 
animal models of disease with a clear pathway to improving 
human health. One example is a core resource devoted to 
studying human breast cancer tumors in living organisms. 
e Human and Mouse Linked Evaluation of 
Tumors (HAMLET) Core is led by breast cancer 
expert Matthew J. Ellis, MD, PhD, director of 
Breast Oncology at Washington University  
and co-leader of the Breast Cancer Research 
Program at the Alvin J. Siteman Cancer Center 
at Barnes-Jewish Hospital and Washington 
University School of Medicine.
 With this resource, researchers can study 
living tumor cells in a preclinical model. e 
growing tumors are genetically similar or identi-
cal to the original tumor and they provide excel-
lent test subjects for developing new imaging 
techniques and performing early studies of new 
drugs and therapeutics. 
A major success stemming from this rela-
tively new core resource culminated in a paper 
published in Nature in 2010. e study looked 
at four DNA samples from a single patient with 
basal-like breast cancer, an aggressive form of 
the disease more common in younger women 
and African-American women. e four samples 
came from the patient’s primary tumor, periph-
eral blood, a brain metastasis, and a primary 
tumor sample grown by the HAMLET Core. 
e HAMLET Core tumor diered in 
important ways from the primary tumor and 
had remarkable similarities to the tumor that 
had spread to the patient’s brain. Such evidence 
sheds light on the mystery of how cancer metas-
tasizes and suggests that a small number of cells 
in the main tumor can give rise to secondary 
tumors that spread throughout the body. 
“Basically what’s growing in the mouse is another metas-
tasis — the most malignant version of the tumor,” Ellis says. 
“So this resource is helping us model the most deadly types 
of breast cancer, and that’s what we need to focus on. We 
want to make these models freely available and collaborate 
widely to solve an extremely complicated biological problem.”
Since the Nature study, an additional 16 models have been 
deeply sequenced and those ndings were released at the 
recent American Association of Cancer Research meeting. 
e ndings show that human-in-mouse copies of breast 
cancer are very clearly excellent genomic and functional 
mimics of the disease. e approach is so promising that 
the HAMLET Core plans to expand and include additional 
tumor types, likely starting with pancreatic cancer. 
modeling
deadly cancers
may lead
to new
treatments
Matthew J. Ellis, MD, PhD
advanced 
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high-tech
imaging
bridges
research and
application
Another important goal of the ICTS is to help    more investigators take advantage of the university’s 
existing technology. A prime example is the ICTS Human 
Imaging Unit, housed in the Center for Clinical Imaging 
Research (CCIR) in the Mallinckrodt Institute of Radiology.  
e ICTS Human Imaging Unit is led by 
Robert C. McKinstry, MD, PhD, professor  
of radiology and of pediatrics, and provides  
access to ve state-of-the-art imaging scanners. 
Pamela K. Woodard, MD, professor of radiology 
and of biomedical engineering, leads the CCIR.
“We want to make sure researchers know 
that this resource is available to them and that 
funding opportunities exist to support pilot 
projects that can then be used to apply for larger 
grants,” Woodard says. “Our equipment is dedi-
cated to research, making it easier to schedule 
time on the machines.”  
As important as access to the scanners 
themselves, the Human Imaging Unit connects 
researchers with expert radiology sta and  
faculty, making it possible for investigators to 
use the equipment regardless of their level of 
experience with human imaging. 
In one example, the Human Imaging Unit 
helped develop imaging methods to evaluate 
how well the placenta is functioning in late 
pregnancy. “e researcher wanted to investi-
gate the health of the placenta and how that is 
aecting the fetus in utero,” McKinstry says.  
“So our sta helped him develop a protocol to 
measure placental morphology, size and chemi-
cal makeup for clues as to whether the placenta 
is ‘running out of gas’ and putting the fetus 
at risk. e investigator knew the question he 
wanted to answer, but he didn’t know how to 
use imaging to answer it.”
 e scanning tools also let researchers  
image a beating heart in near real time; easily distinguish 
bone, so tissue and uid; and create two- and three- 
dimensional images. e equipment includes two MRI  
scanners, a CT scanner, a combined PET-CT machine and  
a PET-MRI system. 
Because imaging is oen a key bridge between animal 
studies and human application, the CCIR serves an impor-
tant role in translating basic science from preclinical areas 
into clinical research areas. e CCIR is one of only ve 
or six facilities in the United States that has a PET-MRI 
machine. Cutting-edge instrumentation like the PET-MRI, 
as well as the presence of multiple high-end imaging systems 
all in close proximity, make the CCIR a world-class  
translational imaging research facility, says McKinstry. 
Robert C. McKinstry, MD, PhD, and Pamela K. Woodard, MD
bright  
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NERVE
DAMAGE
SKIN
INFEC TIONS
FAT T Y LIVER
DISEASE
DEPRESSION
KIDNEY
DISEASE
HEART
FAILURE
FERTILITY
PROBLEMS
FOOT
AMPUTATION
BLINDNESS
COMPL IC AT IONS
D I A B E T E S
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GUM
DISEASE
HERITABLE
RISKS
B Y  L E E  P H I L L I O N
C O M P L I C A T I O N S
A growing epidemic.  
A spectrum of diseases.D I A B E T E S
I F C U R R E N T T R E N D S C O N T I N U E ,
as many as one in three American adults could have diabetes by
2050. is growing problem — U.S. Centers for Disease Control
has called it “an emerging epidemic” — is already impacting an
alarming number of people nationwide.
Nearly 26 million individuals in the United States are living
with diabetes — an estimate that includes roughly 7 million
people who remain undiagnosed. Among those age 65 and older,
almost one in four have diabetes. e cost of diabetes, now over
$100 billion annually, will likely grow along with the prevalence
of the disease.
It’s this looming health crisis that drives the School of
Medicine’s Diabetes Research Center (DRC). Located in the
Department of Medicine and now in its 36th year of National
Institutes of Health (NIH) funding, the DRC is a hub for multi-
disciplinary collaborations, making steady progress in uncovering
the mechanisms involved in diabetes and its complications.
 Washington University’s DRC is one of 16 centers supported
by the National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK). Its established and comprehensive research
bases in diabetes and related areas of endocrinology and
metabolism ensure that scientic investigation is evolving to
meet this major public health challenge. C O N T I N U E D  O N  P A G E  2 0 »
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If you think only of blood sugar when you think 
of diabetes, think again. Consider how diabetes 
aects the entire body: If not carefully managed, 
it can quickly become life-threatening. e 
Diabetes Research Center at Washington 
University brings together experts from diverse 
disciplines to understand the systemic eects  
of this increasingly common disease.
Vital key
Lipid overload
Like a pass key, the hormone insulin 
opens the door, enabling cells 
to use glucose delivered by the 
bloodstream. Without this key, this 
important fuel cannot be efficiently 
used and stockpiles in the blood.
Insulin is also an important key to 
fat metabolism. Without appropriate 
insulin action, fats build up in  
tissues and the bloodstream.
The ravages of diabetes
G L U C O S E
L I P I D S
H E A D  TO  TOE
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Lipid overload
Body-wide affects
Insulin is also an important key to 
fat metabolism. Without appropriate 
insulin action, fats build up in  
tissues and the bloodstream.
IN
FO
RM
AT
IO
N 
GR
AP
HI
C 
BY
 E
RI
C 
YO
UN
G 
• S
CI
EN
CE
 D
AT
A 
BY
 JE
AN
 E
. S
CH
AF
FE
R,
 M
D
1
2
T Y P E
T Y P E
NERVOUS SYSTEM   
Nerve damage leading to pain,  
loss of sensation, abnormal 
neuroregulation
MENTAL HEALTH   
Depression, emotional distress 
VISION   
Glaucoma, cataracts, retina 
disorders leading to blindness
ORAL HEALTH   
Gum disease
GASTROINTESTINAL SYSTEM   
Fatty liver disease
URINARY SYSTEM 
Urinary tract infections,  
kidney failure
GESTATION   
Pregnancy complications, fetal 
developmental abnormalities, 
health risks passed on to children
SEXUAL HEALTH   
Menstrual irregularities, fertility 
problems, hormonal imbalances, 
erectile dysfunction  
FEET   
Sensory diminishment,  
skin changes, ulcers leading  
to amputation
SKIN   
Infections
C ARDIOVASCULAR 
SYSTEM   
Heart attack, peripheral 
vascular disease, hypertension, 
stroke, heart failure
Type 1 diabetes results  
after an overactive immune 
system destroys insulin-
producing cells in the 
pancreas and leads to 
insulin deficiency. An energy 
crisis ensues: Despite high 
circulating blood sugar levels, 
cells in the body cannot 
effectively use the sugar 
without insulin injections.
Genetic factors, inactivity, 
poor diet and weight gain 
can lead to metabolic 
imbalances and resistance 
to insulin action. Initially 
insulin levels increase to 
compensate. However, 
blood sugar levels rise as 
the pancreas fails to make 
enough insulin to  
overcome this resistance.
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As director of the Diabetes Research Center (DRC), 
Jean E. Schaer, MD, the Virginia Minnich Distinguished 
Professor of Medicine, has a panoramic view of research 
underway at Washington University aimed at understanding 
and nding treatments and ultimately a cure for diabetes. 
Schaer spearheaded the recent competitive renewal for  
NIH funding that will propel the DRC forward for the next  
ve years. 
e DRC’s 111 members from across the school have 
joined forces around intersecting areas of interest to under-
stand the basic processes involved in diabetes and its com-
plications and to translate discoveries into better patient 
care. DRC funding provides support for technical expertise 
in state-of-the-art core facilities, a robust pilot grant pro-
gram to jump start the most exciting new ideas in diabetes 
research, and a vibrant enrichment program of seminars  
and courses that stimulates the exchange of ideas.
“Multidisciplinary research is the paradigm for the  
DRC,” says Schaer. “e systemic, chronic and complex 
nature of diabetes requires a multidimensional approach, 
and our members are working across the spectrum of  
immunology, metabolic regulation, and the end-organ  
complications of diabetes.”
A brief tour of major organs aected by complications of 
diabetes illustrates the scope of investigations connected 
through the DRC. e tour begins with the most complex 
organ — the brain. Weighing in at just 2 percent of body 
mass, the brain accounts for 25 percent of body glucose  
utilization, and uctuations in glucose supply to the brain 
can dramatically aect its function.  
Tamara Hershey, PhD, professor of psychiatry,  
neurology and radiology, uses sophisticated in vivo brain 
imaging coupled with neurobehavioral measurement tech-
niques to determine how exposure to glycemic extremes 
impacts brain structure and function in children and adults 
with type 1 diabetes.
Hershey also leads the rst long-term group study 
of brain vulnerability in Wolfram Syndrome, a rare 
monogenic form of juvenile-onset, insulin-dependent  
diabetes that is associated with neurological com-
plications including early blindness. is longitu-
dinal study leverages advances in the diagnosis and 
molecular underpinnings of the syndrome made by 
the late M. Alan Permutt, MD, the former director of 
the DRC, and Fumihiko Urano, MD, PhD, the Samuel 
E. Schechter Professor of Medicine.
is study of Wolfram Syndrome patients will identify 
biomarkers and support clinical trials of specic treatment 
agents and serve as proof-of-principle for more genetically 
and environmentally complex forms of diabetes.
Our next stop is the eye. Diabetic retinopathy, caused by 
changes in the blood vessels behind the retina, is seen in 
up to 45 percent of people diagnosed with diabetes and is a 
leading cause of blindness in adults.
“Eye health is directly correlated to glycemic control in 
diabetic patients,” says Rajendra S. Apte, MD, PhD, the Paul 
A. Cibis Distinguished Professor of Ophthalmology and 
Visual Sciences. “Sometimes it is the eye specialist who rst 
diagnoses the disease from its complications in the eye.”
Apte has found that immune cells called macrophages 
regulate the development of damaging blood vessels in not 
only diabetic retinopathy, but also in age-related macular 
degeneration and in retinopathy of prematurity (formerly 
known as retrolental broplasia), which aects prematurely-
born babies. 
Apte’s research into the molecular factors that lead to 
macrophage changes may open new opportunities for cost-
eective treatments of all of these conditions.
  
Cardiovascular disease is the leading cause of death in 
patients with type 2 diabetes, and the DRC has an impressive 
depth and breadth in understanding diabetic cardiovascular 
complications. Carlos Bernal-Mizrachi, MD, assistant profes-
sor of medicine and of cell biology and physiology, has dem-
onstrated the importance of vitamin D deciency in patients 
with type 2 diabetes.  
Diabetes complications can include 
blurred vision caused by damage to 
the retina and bleeding within the 
eye fluid. A treatment performed 
by Rajendra S. Apte, MD, PhD, takes 
place under subdued red lighting, 
permitting his precise visualization 
of a few millimeters of tissue while 
allowing the surgical team to see 
within the darkened room.
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“Low vitamin D levels nearly double these patient’s rela-
tive risk of developing cardiovascular disease,” notes Bernal-
Mizrachi. His work has revealed new insights into the 
mechanisms that link vitamin D signaling in immune cells 
to cholesterol deposition and atherosclerotic plaque develop-
ment in diabetes. 
Bernal-Mizrachi is the principal investigator of two ran-
domized controlled interventional trials to assess the eect 
of vitamin D supplementation on blood pressure and sub-
clinical markers of cardiovascular disease in diabetes. 
Cardiologist Sharon Cresci, MD, assistant professor 
of medicine and genetics, wants to understand 
why patients with diabetes suer from a more 
aggressive form of heart disease. Lever-aging 
aer surgery and achieve a 10-fold decrease in acute rejec-
tion rates, both of which improve long-term outcomes.
“Over the last eight years, our transplant team has also 
steadily increased the number of kidney-pancreas trans-
plants or pancreas transplants alone for selected patients,” 
says Brennan. “ese provide better diabetes-related and 
overall quality-of-life improvements.”
 Program surgeons perform around 220 kidney trans-
plants and between 15 to 20 combined or sequential kidney- 
pancreas transplants annually. While the majority of patients 
who undergo sequential kidney-pancreas transplant have 
type 1 diabetes, data suggest that the procedure also confers 
signicant benets for some patients with type 2 diabetes.
The final stop on the complications of diabetes excursion 
is a visit to the laboratory of Kelle H. Moley, MD, the James 
P. Crane professor of obstetrics and gynecology, who is an 
expert in reproductive endocrinology and infertility. 
Men with diabetes can suer testicular dysfunction, impo-
tence and decreased fertility. In women, diabetes and obesity 
are associated with an increased risk of reproductive compli-
cations, including fetal loss and congenital malformations.
Moley’s research has provided key insights into the  
consequences of early fetal exposure as well as preconception 
gamete exposure to high concentrations of glucose, insulin 
and/or fatty acids  and the eects of the drug metformin 
on miscarriages. Her work has improved understanding of 
pregnancy failure among women with diabetes. Other recent 
work suggests that systemic insulin insuciency and result-
ing decreased hypothalamic-pituitary-testes axis signaling 
are the key detrimental factors responsible for subfertility 
among diabetic men.
Daniel C. Brennan, MD,  
follows up with patient 
Padma Jampala, who  
underwent a successful  
kidney transplant in 2004.
Systemic, chronic and complex, diabetes 
requires a multidimensional approach. 
her background in cardiovascular disease, 
metabolism and genetics, Cresci helped 
design a custom microarray chip that she then 
used to discover the rst genetic variant associated 
with severity of coronary artery disease in patients 
with type 2 diabetes. Findings such as these hold promise for 
more eective clinical management through genotype-based 
personalized treatments.
ese types of clinical investigations are complemented  
by groundbreaking basic discoveries in the eects of diabetes  
on blood vessels and heart muscle in the laboratories of 
investigators including Clay F. Semenkovich, MD, the 
Herbert S. Gasser Professor and co-director of the DRC.
Moreover, the concentration of research excellence in the 
area of diabetic heart and vascular complications spurred 
the formation of the Diabetic Cardiovascular Disease Center 
(DCDC), one of the school’s BioMed 21 interdisciplinary 
research centers. Institutional resources for the DCDC, co-led 
by Schaer and Daniel S. Ory, MD, professor of medicine 
and of cell biology and physiology, have proven instrumental 
for several recent successful NIH funding applications for 
diabetic complications research at Washington University. 
Diabetic nephropathy is another common and devastating  
complication that can result in end-stage renal disease. DRC 
member Daniel C. Brennan, MD, professor of medicine,  
leads one of the most experienced kidney transplant and 
transplant nephrology programs in the United States.
Nationally, approximately one-third of kidney transplant 
patients present with diabetes. And of those who do not, up 
to 20 percent will develop diabetes within a year aer trans-
plant. By studying new immunosuppressants and induction 
agents, Brennan’s team has been able to reduce post-trans-
plant onset of diabetes to just 5 percent within the rst year ROB
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Interdisciplinary teamwork in health care isn’t just a concept — it’s a reality. e constantly evolving nature of the U.S. health care system makes well-coordinated 
collaborations across medical professions a necessity. 
At Washington University School of Medicine, students 
from multiple programs are actively building bridges  
among professions even before they begin their careers.  
e Health Professionals Student Leadership Council 
(HPSLC) was created by students in 2010 to promote  
and advance the understanding of collaboration among 
professions in providing eective patient care.
“HPSLC has three main goals,” explains group presi-
dent Michele Ionno, a second-year student in the school’s 
Program in Physical erapy. “e rst is to improve com-
munication among students from various disciplines. e 
second is to improve knowledge of what each discipline 
oers in the clinic. ird, and most importantly, we want to 
show students how working together improves patient care.”
e group includes Washington University students  
from the medical, occupational therapy, physical therapy, 
audiology and communication  
sciences, and Division of Biology 
and Biomedical Sciences  
programs, and students  
from the St. Louis College  
of Pharmacy and the  
Goldfarb School of Nursing  
at Barnes-Jewish College.
Although HPSLC’s mem-
bers are located on or near 
the Washington University 
Medical Center campus, 
opportunities for students  
to interact has been limited.
HPSLC is determined to 
change that. e group regu-
larly brings members from all 
of the professions together at 
various academic and com-
munity outreach events. 
ese include featured lunch 
talks, an activities fair, case 
study reviews, and an annual 
Community Service Day.
Students from diverse training 
programs work together to answer 
questions posed by faculty during a 
recent case study presentation.
Now
BY  HOLLY  EDMISTON
Getting different professions 
talking — and working — 
together, for the greater good
talking
we’re
practice
clinic
communication
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During case study reviews, faculty pose questions to  
interprofessional groups of students.
 “Each round of questions represents a dierent set- 
ting for the patient as he or she moves through the health 
care system,” explains Gloria Grice, associate professor of 
pharmacy practice and associate director of experiential  
programs at the St. Louis College of Pharmacy (STLCOP). 
“It’s fun for the students because they are all very competi-
tive and enjoy being challenged, but it’s not ‘high stakes’  
like their actual coursework.”
ird-year medical student and former HPSLC president 
Elaine Khoong agrees. “All the students 
really enjoy the experience. Not only is  
it informative and instructive, it’s also 
synergistic with the formal curriculum  
in that it helps us become better prepared 
to apply what we have learned in the 
classroom to what we will eventually  
do in clinical practice.” 
Community Service Day, held early  
in the academic year, is geared toward 
rst-year students. It promotes collab-
oration among students in the dierent  
programs as well as community-building 
in the city of St. Louis.
“It’s really important for students to 
know how to interact as professionals,” 
says Lauren Lewis, a second-year student 
in the school’s Program in Audiology and 
Communication Sciences (PACS) and secretary of HPSLC, 
“but also on a more personal level to get to know one 
another. And it’s great to be welcomed into the community 
not only as clinicians, but as people who can give back to the 
city in which they live.”
In 2012, more than 120 students in teams of 10 worked 
with established community organizations at a variety of 
sites — from participating in a neighborhood cleanup with 
members of St. Louis Arc, a group that supports people with 
developmental disabilities, to painting and assisting with 
childcare at Lydia House, which provides transitional hous-
ing for abused women and children.
“For incoming students, Community Service Day is a 
great way to get to know St. Louis and the wonderful organi-
zations that are established here,” says Casey Krauss, who is 
working on her master’s degree in deaf education. “I moved 
here from Michigan and have found that many students tend 
to stick to their own programs for socializing. But I feel that 
I met people who have become some of my greatest friends 
at Community Service Day.”
Script Your Future, a national campaign HPSLC recently 
participated in, gave students from all of the professions 
opportunities to meet with community members at more 
than 24 locations to address concerns about medication 
adherence and its importance in maintaining good health. 
“Each profession has its own language and frame of  
reference,” says HPSLC vice president 
Sarah Cheatham Oberle, a second-year 
student in the school’s Program in 
Occupational erapy. “We want our  
students to work with other practitioners 
to learn the language they speak and 
what they bring to patient care. We need 
to work together as a team to provide 
continuity of care for our patients, and 
we really believe that mindset needs to 
start in graduate school.”
Cheatham Oberle has been active in 
developing HPSLC’s shadowing program, 
which provides an opportunity for stu-
dents to meet and observe practitioners 
from professions other than their own. 
While the list of participants is relatively 
small, the group is actively recruiting  
for additional mentors. Expanding the shadowing program 
and continuing to build on other successful initiatives are 
top priorities for HPSLC.
“Collaborative learning leads to teamwork in the real-
world health care setting and, most importantly, improves 
patient care by increasing coordination of services,” says 
Alison J. Whelan, MD, senior associate dean for education. 
“Collaboration also has implications for the bottom line, in 
that more ecient care maximizes prevention, which may 
then decrease the burden on acute care facilities. 
“Washington University School of Medicine students 
and their peers in HPSLC are prepared to meet the need 
for enhanced collaboration, and by embracing the need for 
teamwork across multiple professions, they are actively pre-
paring to meet the health care challenges of the future.”
“Each profession  
has its own  
language and  
frame of reference.”
 —SAR AH C HE AT HA M O B ER L E ,  OT D ’13 
Community Service Day 
brings students together.
clinic
health
care
team
interaction
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Seriously, folks!  
Clown arts enhance 
the healing arts.  
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“Keland came to the Program in Occupational erapy 
with a passion for circus arts,” says Gronski. “He knew from 
his experiences that they have tremendous therapeutic value 
— he just needed an avenue to prove it. When he approached 
me with this idea, I was admittedly hesitant. It was ‘out-
side the box’ of the intervention I currently provide at CID. 
However, the collaboration could not have had better results.”
Scher presented his research ndings at the program’s 
annual scholarship day and at the American Occupational 
erapy Association’s annual meeting held in April.
Among the qualitative results were teachers’ comments, 
which suggest that the children who participated grew in 
condence. One teacher noted “…[the children] were very 
proud of themselves ... and they learned that dropping a ball 
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Call Keland Scher a clown and he’ll consider it a compliment. Accuse him of clowning around in the classroom and you’ll be technically accurate. Scher, 
a master’s degree candidate in occupational therapy set to 
graduate this May, wholeheartedly embraces the art of play. 
Scher’s educational background and life experience are  
a bit dierent compared to the majority of students in the 
School of Medicine’s Program in Occupational erapy. 
Before coming to Washington University, he earned a 
diploma from Ringling Bros. and Barnum & Bailey Clown 
College in Florida and, aer graduation, “rode the rails” for 
a year performing. He also worked for ve years with the  
Big Apple Circus Clown Care unit in hospitals, nursing 
homes and camps for children with life-threatening illnesses. 
In addition to his clowning credentials, Scher also holds 
a bachelors of ne arts in theatre from Miami of Ohio 
University and a masters of ne arts and a teaching of move-
ment for actors’ diploma from York University in Toronto.
He had planned a career as an actor and teacher. But 
while teaching a movement for performance class to stu-
dents at Roosevelt University in Chicago, Scher realized he 
cared more about the classes that were physically beneting 
students than how they could integrate those movements 
into the characters they portrayed.  
“I knew I wanted to nd a therapeutic container for all the 
work I was doing,” says Scher. “at’s when I came upon an 
article in the Australian Occupational erapy Journal and 
realized that occupational therapy would t the bill.”
He applied to several schools, but quickly 
chose the Program in Occupational erapy 
at Washington University due to its science-
based nature and high ranking.
Once in St. Louis, Scher knew he’d made 
the right decision. “e faculty has been sup-
portive by allowing me to take my skill as a 
teacher and circus artist into research,” he says. 
Scher recently completed a study involv-
ing participants from Central Institute for 
the Deaf (CID), with Meredith Gronski, 
OTD, OTR/L, serving as his mentor. “Dr. Gronski opened 
up her research lab to circus arts,” Scher says. “It takes a 
trusting soul in a medical school to allow this.”
According to Scher, previous research has shown that 
children who are deaf or hard of hearing have diculty with 
basic communication skills such as collaboration or social 
participation. Scher developed a 10-week course to deter-
mine how using circus arts as an intervention could help 
these children to improve their social skills, tapping into 
their motivation and encouraging self-ecacy.   
Working mainly with eight- to 12-year-olds, Scher set 
about teaching the children how to juggle, spin plates, walk 
and balance on a giant ball, and work together to build a 
pyramid. e study culminated with a 40-minute perfor-
mance for the participants’ parents and teachers.
Keland Scher performs at a recent coffehouse event held at the School of 
Medicine’s Farrell Learning and Teaching Center. 
meant another opportunity to try again, not failure.”  
Scher considers himself fortunate to be able to bring 
his experience in teaching and his passion for circus arts 
together while at Washington University, while Gronski con-
siders the program fortunate for Scher’s innovative thinking.
“Children who are deaf and hard of hearing oen transi-
tion into public educational arenas with hearing peers,”  
says Scher. “e more opportunities they have for social 
interactions that foster trust, mutual respect and positive 
risk-taking, the better equipped they will be to succeed.” 
Gronski agrees. “Not only did Keland foster these skills 
in the children at CID, but he really is pushing the eld of 
occupational therapy forward. And accommodating his  
project exemplies the Program in Occupational erapy’s 
commitment to innovative practice.”
“I enjoy empowering others through  
physical and vocal expression, helping them to grow,  
change and transform. Occupational therapy in  
tandem with circus arts has the potential to be a  
powerful combination.” — Keland Scher, MSOT ’13
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Understanding  
the brain BY  STEPHANIE  STEMMLER
e number of people aected by degenerative brain diseases is 
growing as the population ages, while mental illness aects 1 in 4 
adults and 1 in 5 children in the United States. In multiple ways,  
we see the physical, emotional, and nancial toll of brain disorders 
and diseases upon society.
 Our researchers have developed a highly accurate diagnostic 
tool for autism and are homing in on the disease’s genetic triggers. 
We are leading worldwide clinical trials to test new drugs that may 
prevent or halt the progression of Alzheimer’s disease and dementia. 
Investigators at Washington University are leading a coalition of 
scientists who are undertaking the eort to map the human brain.   
 At the School of Medicine, there is a conuence of research 
expertise and a rich legacy of pioneering advances in neurosciences 
that goes back more than 50 years. Diverse collaborations are 
underway in elds such as neurosurgery and neurology, psychiatry, 
neuroimaging, molecular biology, and pathology — all trying to 
unravel the enigma that is the human mind and brain.
 e eld of neurosciences is poised to make signicant 
medical advances over the next two decades. With your support, we 
can lead the way in this important area of research and clinical care.
We invite you to be a part of this historic endeavor.  
e timing is right to advance the eld of neurosciences.
Leading Together The Campaign for Washington University
Janice W. Brunstrom-
Hernandez, MD, director 
of the Pediatric Neurology 
Cerebral Palsy Center, with 
young patient Bryn Adams 
and her dad, Keith.
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Realizing that the stigma needs to be lied 
from the diagnosis of mental illness, Andrew 
and Barbara Taylor and the Crawford Taylor 
Foundation recently committed $20 million to 
the Department of Psychiatry at Washington 
University School of Medicine to advance research 
into the diagnosis and treatment of mental illness.
“Our own families have been touched by 
these illnesses over several genera-
tions,” says Andrew C. Taylor, chief 
executive ocer and chairman of 
Enterprise Holdings. “In the news, 
we hear of so many tragedies involv-
ing mental illness. We, as a country, 
need to become better informed  
and support the research going on 
that can better treat or prevent  
these diseases.”
e generous gi will support  
the establishment of the Taylor 
Family Institute for Innovative 
Psychiatric Research.
“Our department has played  
a leading role in advancing criteria-based  
psychiatric diagnoses, and we’re now focused  
on nding new treatments as well as trying to  
better understand the mechanisms that trigger  
these disorders in the brain,” says Charles F. 
Zorumski, MD, the Samuel B. Guzé Professor  
and head of the Department of Psychiatry.
 “Psychiatry has a huge problem in that cur- 
rent treatments are good, but not good enough  
for a signicant number of people who either  
don’t respond to current medications or experi-
ence serious side eects,” says Zorumski, who  
also is a professor of neurobiology. “ere is an 
incredible message in the gi from the Taylor  
family in that they want us to nd better treat-
ments to help those with mental illnesses who 
oen have no other voice in society.”
“We put our family name front and center 
because we thought it could be a beacon, that it 
might attract interest both in psychiatry and the 
world of philanthropy,” says Taylor. “It’s going 
to take more gis, large and small, to accelerate 
research into psychiatric disorders, and my hope  
is that this will yield another class or several 
classes of medications that can better address 
these illnesses.
“Since this gi was announced, I have  
received notes from people around the country 
who have been impacted by mental illness. What 
they tell me is that they now have a sense of hope 
— someone is paying attention. I want many 
people to pay attention because I think awareness 
promotes momentum.”
Barbara and Andrew Taylor support ongoing research into the diagnosis, treatment, and prevention of mental illness.
A mental health focus
“We put our family name
front and center because
we thought it could be a
beacon, that it might attract
interest both in psychiatry
and philanthropy.”
— ANDREW TAYLOR
28  Washington University School of Medicine
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The first worldwide human testing of  
three investigational drugs to determine if they 
can prevent Alzheimer’s disease dementia is being 
led by researchers at Washington University.
e trial involves 240 people, all from fami-
lies with rare inherited genetic mutations. ose 
who inherit the mutation are certain to develop 
Alzheimer’s. e academic medical centers 
involved with the trial are connected 
through an international research 
study, the Dominantly Inherited 
Alzheimer Network (DIAN), led by 
John C. Morris, MD, the Harvey A.  
and Dorismae Hacker Friedman 
Professor of Neurology and director 
of the Charles F. and Joanne Knight 
Alzheimer’s Disease Research Center.
“As more and more baby boomers 
move into this age of 65 and older, 
we’ll see an explosion of people with 
Alzheimer’s disease and dementia,” 
says Morris, calling it a public health 
disorder of epidemic proportions. 
“We want to prevent damage and loss of brain 
cells by intervening early in the disease process 
— even before outward symptoms are evident,” 
says Randall J. Bateman, MD, the Charles F. 
and Joanne Knight Distinguished Professor of 
Neurology and principal investigator of the grant 
and director of DIAN. 
Washington University has been leading the 
eld of Alzheimer’s disease research for more than 
20 years. It is here that scientists discovered that 
degenerative changes in the brain begin 15 years 
before signs of dementia become apparent. 
 ”ere are an estimated 5.5 million people  
with dementia due to Alzheimer’s right now,” 
says David M. Holtzman, MD, the Andrew B. 
and Gretchen P. Jones Professor and chair of the 
Department of Neurology, “and that number is 
expected to triple by 2055.” 
Basic research has shown that the build-up of 
two proteins in the brain, one somehow triggering 
the accumulation of the other, occurs in patients 
with Alzheimer’s. Holtzman’s lab and others are 
working to nd ways to decrease the build-up of 
both of the proteins. An added hope is that a fast, 
reliable measure, such as a blood test, will allow 
diagnosis of Alzheimer’s disease early enough so 
that new medications can stop the accumulation of 
proteins and thus prevent brain degeneration.
“We hope these new drugs not only hit the  
target protein but also slow the process of degenera-
tion,” Holtzman says. “Because of research  
now underway, there is denite hope that at some 
point we will be able to prevent this disease.”
David M. Holtzman, MD, with patient Lynn Burlingame in the Charles F. and Joanne Knight Alzheimer’s Disease Research Center.
Defeating Alzheimer’sA mental health focus
“We want to prevent
damage and loss of brain
cells by intervening early
in the disease process
— even before outward
symptoms are evident.”
— RANDALL J. BATEMAN, MD
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With non-identical twin teen boys, both 
diagnosed with autism, Bassam and Jumana 
Al-joundi have tried for years to nd care,  
ongoing treatment, and hope.
 “Having two children with autism is a huge 
responsibility to myself, God, my husband, and 
my boys,” says Jumana Al-joundi. “It is very  
challenging, but I could never imagine myself or 
my life without them.” Her hus-
band, Bassam N. Al-joundi, MD, 
agrees. “As parents, we try anything 
we can to help our children,” he 
says. “It’s been a long struggle.”
e Al-joundis’ situation mirrors 
studies that show some 15 percent 
of families who have a child with 
autism have a second child with the 
same disorder, sparking investiga-
tion into autism’s genetic risk factors. 
In groundbreaking research, 
Washington University psychiatrists 
identied subtle social decits, lan-
guage impairments, and repetitive 
behaviors in many unaected siblings of children 
with autism. is provides important clues about 
how autism is transmitted in families.  
“What’s equally surprising is how these traits 
‘travel together’ in children without autism; they 
are as tightly correlated in siblings and in the general 
population as in the autistic syndrome itself,” says 
John N. Constantino, MD, the Blanche F. Ittleson 
Professor of Child Psychiatry and co-director of 
the Intellectual and Developmental Disabilities 
Research Center.
“e strong connection between these seem-
ingly dierent aspects of behavior was our rst clue 
that what goes awry in autism is an extreme ver-
sion of what results in normal variation in social 
development,” says Constantino. “e science of 
autism, then, is really the study of human social 
behavior, where autism represents the extreme of a 
developmental continuum.”
Constantino and his colleagues are trying 
to determine why more boys than girls develop 
autism and how autism risk is transmitted in 
families, oen through unaected parents. Other 
Washington University researchers are conducting 
brain-imaging studies on infants at risk for devel-
oping autism to see if early signs of the disease can 
be pinpointed. 
“is city needs a comprehensive autism  
center and coordinated resources to help fami-
lies like ours over the long term,” says Bassam 
Al-joundi. “Research is important, but the added 
emphasis that Washington University will put on 
treatments and care for autistic children is vital.”
Success with autism
“Having two children
with autism is a huge
responsibility. It is very
challenging, but I could
 never imagine myself or
my life without them. ”
— JUMANA Al-JOUNDI
John N. Constantino, MD, far right, with the Al-joundi family, from left: Jumana, Mohamad, Bassam, and Nizar.
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Diseases of the muscles and nerves 
range from the uncommon to the very familiar. 
Common symptoms include weakness and sensa-
tions of numb or tingling hands and feet.
In just the last several years, researchers at 
Washington University have discovered new  
genetic forms of neuromuscular diseases — a  
variant form of amyotrophic lateral sclerosis 
(ALS), commonly known as Lou 
Gehrig’s disease, and disorders that 
cause muscle and nerve damage.
ese discoveries point to a 
nationally recognized strength of 
the School of Medicine’s neuro- 
muscular program. “We have the 
combined strength of one of the 
busiest clinical programs for the 
care of patients and a large neuro-
muscular physician research group,” 
says Alan Pestronk, MD, director  
of the Neuromuscular Division.
Researchers in the division 
explore the genetic and autoimmune 
causes of oen devastating diseases that strike 
nerves or muscles, such as ALS, muscular dystro-
phy, myositis, and immune and hereditary nerve 
disorders. Because many of these diseases are  
uncommon, researchers have created a DNA bank, 
a collection for use in ongoing studies that includes 
genetic information from thousands of patients. 
Focused eorts on the genetic causes of ALS 
point to single mutated genes that produce a toxic 
protein. “We now are testing a chemical com-
pound that blocks the production of one such toxic 
protein in human patients,” says Pestronk. “e 
studies are generating hope that we can treat some 
forms of ALS, which currently have no cure.”
Researchers also have identied a serum anti-
body that may point to the cause of some previ-
ously unexplained, painful neuropathies, opening 
the door to the development of new drug therapies. 
More than a decade of research into the auto-
immune causes of chronic muscle inammation 
and weakness has led to the creation of an excit-
ing and specic muscle biopsy diagnostic process. 
“Just by looking at muscle through the micro-
scope, we can tell the kinds of myopathies patients 
are likely to develop and which treatments are 
likely to be eective,” Pestronk says. 
More funding would enable the division  
to accelerate eorts to identify the genetic and 
immune triggers for neuromuscular diseases.  
“In many diseases that we treat,” says Pestronk, 
“we are getting better ideas of the molecular 
mechanisms that cause them, which means  
eective treatments are closer to reality.”
Neuromuscular study
“Just by looking at muscle
through the microscope,
we can tell the kinds of
myopathies patients are
likely to develop and which
treatments are likely
to be effective.”
— ALAN PESTRONK, MD
Alan Pestronk, MD, director of the Neuromuscular Division, with patient Gretchen Miller in the neurology clinic.
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Collaborative efforts
Brain diseases such as stroke, Parkinson’s  
disease, multiple sclerosis, amyotrophic lat-
eral sclerosis (ALS), and Alzheimer’s disease 
are among our nation’s most signicant health 
problems, aecting 50 million Americans. More 
research is needed if we are to treat these illnesses 
more eectively and someday even prevent them.
“I would not be here if medical research had 
not extended my life,” says  
William H. Danforth, MD, vice 
chairman and chancellor emeritus 
of Washington University. “I have  
a personal reason to be grateful. 
And so do many others.”
As science continues to shed  
new light on old problems, some-
times one disease, such as cerebral 
palsy, can be seen as part of a family 
of diseases — in this case, neuro-
degenerative diseases.
If that group of diseases is  
then studied by a multidisci- 
plinary group of researchers, the 
collaborative eort could result in more rapid  
scientic breakthroughs focused on prevention 
and treatment.
“It makes sense for more scientists and physi-
cians to come together around common central 
facilities and databases for a family of diseases 
rather than a single disease,” says Danforth.  
“ey can draw more eectively from diverse  
elds such as genetics and immunology.”
Washington University School of Medicine is 
leading a collaborative eort to prevent, diagnose 
and treat a wide range of neurodegenerative  
diseases. e Hope Center for Neurological 
Disorders was established in 2004. e center 
brings together more than 500 world-class  
scientists in a collaborative environment with  
the goal of rapidly translating basic scientic  
discoveries into direct patient care.
e School of Medicine needs your help to 
escalate research into neurological disorders.  
A generous gi of $10 million from the Danforth 
Foundation is leading the way and encouraging 
others to consider important endowment commit-
ments to support research at the Hope Center. 
“e Hope Center puts together the right 
world-leading scientists, with the right vision,  
and the right infrastructure, to mount an attack  
on these crippling diseases,” says Danforth.  
“e challenge for us all is to join the Hope  
Center in the pursuit of this noble cause.”
“We have the right world-
leading scientists, with
the right vision, and the right
infrastructure, to mount
an attack on these
crippling diseases.”
— WILLIAM H. DANFORTH, MD
Alison Goate, PhD, left, who studies protein aggregation and neurodegeneration, with postdoctoral student Celeste Karch.
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Understanding The Brain
	 n Research support for specic psychiatric illnesses  
 n Support for Alzheimer’s and dementia research 
 n ree- to ve-year funding for pilot projects for autism
 n Genetic research support for neuromuscular diseases
 n Endowed gis to support the Hope Center
 n Endowed fellowships to train future neurosurgeons
 n Support research in brain development and function  
 in the Department of Anatomy and Neurobiology
Cancer and Personalized Medicine   
Diabetes, Heart Disease, and Obesity  
Infectious Diseases and Global Health
The Next Generation:  
Professors, Graduate Fellows, and Students  
The Annual Fund
Together,  
 we can change lives.
Understanding the brain is a critical frontier in
modern medicine. Please consider funding this or
other opportunities to advance human health.
For information
about these and other
opportunities, please
contact:
Pamela Buell
Associate Vice Chancellor
for Medical Alumni and
Development
Phone:
(314) 935-9691
Email:
meddev@wustl.edu
Website:
medicalalumni.wustl.edu /
campaign
Leading Together The Campaign for Washington University
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classnotes
1940 S 
Robert Gibb, MD 48
Gibb has served as president of the 
Western Pathologists Quality Assurance 
Association. He has been involved in the 
establishment of 11 scholarship endow-
ments for schools of medical technology 
or clinical laboratory scientists at 10  
universities and technical institutions.
Roger Fox, MD 49
Fox and his wife are enjoying life about 
one mile from the Pacific Ocean. They 
have four children, eight grandchildren, 
and eight great grandchildren; still enjoy 
traveling; and have been on all seven  
continents and to 44 countries so far.
1950 S 
Robert Hermann, MD 54
Hermann is enjoying retirement, still  
playing some golf and tennis, and  
traveling with his wife, Polly.
David Perkins, MD 55
Perkins and his wife, Marge (Hollan),  
LA 51, were honored recently by the  
Saint Louis Zoo with the individual  
Zoo Award. They also were featured in a  
recent Playbill at the St. Louis Symphony 
for their philanthropic support.
Robert C. Meredith, MD 57
Meredith retired from the practice of  
medicine as a board-certified neuro- 
surgeon in July 2010. He and his wife, 
Joanne (Schwam) Meredith, NU 56, 
have been married for more than 55 years. 
The couple enjoys traveling and spending 
time with their children and grandchildren.
1960 S 
Donald Stewart Jr., MD 61
Stewart and his wife, Anne, have four  
children and 10 grandchildren. He still 
enjoys doing some oil painting.
Carolyn Robinowitz, MD 64
Robinowitz recently completed her tenure 
as editor-in-chief of Psychiatric News 
and currently serves as special associate 
provost for health sciences at George 
Washington University. She enjoys travel-
ing to San Francisco to visit her son, a pedi-
atric anesthesiologist, and grandchildren.
Seth Eisen, MD 66
Eisen has been serving as national  
director of the Veterans Administration’s 
Health Services Research and Develop-
ment program in Washington DC. He and 
his wife, Marion, love the extensive system 
of bicycle trails available in the area and 
the rich American history of the city.
Chuck Robertson, MD 66
Robertson and his wife, Dianne 
Robertson, LA 64, celebrated their 50th 
anniversary with a Mediterranean cruise. 
They enjoyed having their children and 
grandchildren join them on the cruise.
1970 S 
Mark Edelstein, MD 75, GR 75
Edelstein retired from the Veterans Admini- 
stration (VA) in 2011 after working at the 
Detroit VA Medical Center for 27 years.
Linda Hershey, MD 75
Hershey directs a dementia clinic at 
Oklahoma University Medical Center and 
tests new therapies for Alzheimer’s disease.
David Magarik, MD 76
Magarik is soon to become a “grandpa” 
to twins and a father-in-law for the third 
time. He encourages fellow alumni to stay 
curious and look for “the most interesting 
case” and welcomes visitors to stop by and 
visit when in the Shenandoah Valley.
1980 S 
Bart Mandelbaum, MD 80
Mandelbaum recently served at the 
London 2012 Olympics as medical offi-
cer for IOC FIFA for the fourth time. He 
was also recently appointed director of 
research for Major League Baseball.
Steven Perlmutter, MD 80
Perlmutter received his JD magna cum 
laude in 2011. His work concentrates on 
representing health care professionals in 
front of their respective licensing boards.
Bob Mittle, MD 85
Mittle is president of Charlotte Radiology, 
one of the largest private diagnostic radi-
ology groups in the country, and lives in 
Charlotte with his family. His four children 
are very accomplished, including one son 
in his first year of medical school.
1990 S 
Ron Pearson, MD 90
Pearson is serving as the state survey 
agency director for the State of Wyoming.
Jennifer Scheer, MD 94
Scheer is working as a family doctor in 
rural Missouri and is enjoying new  
responsibilities in an administrative role  
as a physician leader.
Mark Cohen, EN 94, MD 98, HS
Cohen is associate professor and vice chair 
of surgery at the University of Kansas 
Medical Center and also recently founded 
a biotech company (NanoPheum), which 
makes safer, more effective chemotherapy 
drugs. He lives in Kansas City with his wife 
and two children.
Jolie Holschen, LA 95, MD 99
Holschen has accepted a new position  
in private practice emergency medicine 
with Infinity Healthcare in Chicago IL.  
She serves on the Sports Medicine Board 
Exam Committee for the American  
Board of Emergency Medicine.  
2000 S
Emily Engelland, MD 01
Engelland is practicing occupational  
medicine and working as the managing 
physician at U.S. HealthWorks Medical 
Group in Robbinsdale MN. She is engaged 
to be married in May 2013.  
Jonathan Chung, MD 04
Chung was elected to the editorial board 
of the Journal of Thoracic Imaging and 
joined the American College of Radiology 
Appropriateness Criteria Panel: Thoracic.
Kevin Wilson, MD 05
Wilson is an assistant professor of otolar-
yngology at the University of Utah in Salt 
Lake City and has four children who keep 
him and his wife, Emily, busy.
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If you wish to make a tribute gift in honor 
of any of the above alumni or faculty, 
please contact: Pamela Buell, Washington 
University Medical Alumni and Development, 
Campus Box 1247, 7425 Forsyth Blvd., Suite 2100, 
St. Louis MO 63105-2161, (314) 935-9691.
Outlook  35
In Memory 
Leo Sachar, MD 40
Sachar died on Dec. 9, 2010. He was chief 
of surgery and president of the medi-
cal staff at Jewish Hospital after serving 
as a U.S. Army surgeon during WWII. He 
enjoyed teaching medical students and 
training surgeons. Later he was vice chair-
man of the board and vice president for 
medical affairs at St. Elizabeth’s Hospital  
in Belleville IL.
Harry Lichtwardt, MD 43
Lichtwardt died on Nov. 22, 2012, at age 
93. During WWII he served as head of 
the medical corps on Okinawa. He later 
practiced medicine in Detroit and helped 
develop a urological practice pioneering 
many developments in urologic equip-
ment and procedures. He served as presi-
dent and historian at the North-Central 
Section of American Urological Associates.
Pauline Stokes, NU 44
Stokes died on Aug. 28, 2012, at age 89. 
She was a registered nurse at Fayette 
County Hospital for many years.
Donald W. Bussmann, MD 45
Bussmann died on Jan. 17, 2011. He was 
90.  After completing medical school, 
he served as a medical officer in the U.S. 
Army. Later in his career, he helped to 
found the Department of Cardiology 
and served as director of the Cardiac 
Auscultation Lab and associate professor of 
internal medicine at Saint Louis University.
Lawrence O’Neal, MD 46
O’Neal died on July 29, 2012, at age 89. 
After completing his medical degree 
during an accelerated wartime program, 
he trained in surgery at Barnes Hospital 
where he then remained on staff. He con-
tributed to medical literature as author, 
editor and reviewer and also engaged in 
clinical research on endocrine subjects. 
He co-edited a volume on diabetic foot 
problems in 1973 that has gone into 
seven editions and been published in 
several languages. For eight years he 
was chairman of the Department of 
Surgery at St. John’s Medical Center and 
also helped develop a program for surgi-
cal training between the hospital and 
Saint Louis University. After retirement, 
he was medical director of the Sisters of 
Mercy Health System. O’Neal received the 
Alumni Achievement Award in 1991 from 
Washington University. He enjoyed writing 
and photography.
Robert J. Glaser, HS 47
Glaser died June 7, 2012, at age 93. Before 
completing residency at Barnes Hospital, 
he attended Harvard Medical School. At 
Washington University, he served as an 
associate professor, assistant dean and 
associate dean before moving to serve 
at the University of Colorado and then 
Stanford School of Medicine, where he 
acted as dean and vice president for medi-
cal affairs in both posts. He received many 
awards and honors during his career and 
was active nationally in medical  
education. 
Janet S. Gilman, MD 49
Gilman died on Jan. 17, 2011 at 86. She 
practiced at Sharp Chula Vista Hospital for 
more than 30 years, many as chief of anes-
thesia and chief of staff. She is remem-
bered as a pioneer of women practicing 
medicine. She was well respected profes-
sionally and liked personally by those with 
whom she worked. She loved pets and 
always had dogs or cats. She is survived by 
her three children and grandchildren.
Melvin Lee Faw, MD 51
Faw died on April 16, 2012. After earning 
two Purple Hearts and three Bronze Stars 
during WWII, he completed his under-
graduate studies. After receiving his medi-
cal degree from Washington University, 
he completed an internship and residen-
cies in internal medicine and cardiology 
at Washington University and Kansas 
University. He practiced internal medicine 
at Welborn Clinic in Evansville IN from 
1955–87, where he was managing partner. 
He is survived by children, grandchildren 
and great-grandchildren.
Jeanne McDonald, NU 54
McDonald died on April 19, 2012. During 
her career she worked at Boone Hospital 
and University Hospital and for the 
Department of Health. She was an active 
member of the Ashland Garden Club 
and enjoyed singing in the church choir. 
Survivors include children, grandchildren 
and great-grandchildren.
Faculty
Helen E. Nash, MD 
Nash, professor emerita (clinical) in pedi-
atrics, died on Oct. 4, 2012. She was 91. In 
1949, she was the first African-American 
physician to join the attending staff at 
St. Louis Children’s Hospital and the first 
African-American woman to join the fac-
ulty of Washington University School of 
Medicine. She served at both institutions 
for more than 40 years. At the same time, 
she maintained a thriving private practice 
at Grand Boulevard and Cass Avenue in 
the African-American business district. In 
1993, Nash retired from medical practice 
and soon began serving as the medical 
school’s dean of minority affairs. During 
her tenure, she was credited with raising 
the academic achievements of minority 
students. Earlier in her career, she also 
served as pediatric supervisor and associ-
ate director of pediatrics at Homer G. 
Phillips Hospital and as president of the 
St. Louis Children’s Hospital attending 
staff. The medical school recognized her 
lifetime contributions by creating the  
Dr. Helen E. Nash Academic Achievement 
Award. Nash was heralded by physicians 
throughout St. Louis for her commitment 
to excellence, tireless advocacy on behalf 
of children, and endless enthusiasm for 
the field of medicine.
Alfred I. Sherman, MD 55
Sherman died on Aug. 25, 2012. He was 
91. After training in urology and pathol-
ogy, he followed his mentor, Willard Allen, 
MD, to Washington University and Barnes 
Hospital in St. Louis, staying 20 years. He 
later served on the faculty at Wayne State 
University School of Medicine and as head 
of the obstetrics/gynecology department  
at Sinai Hospital in Detroit MI. After 
retiring from Sinai in 1975, he went into 
private practice and continued teaching, 
lecturing and writing until he “officially” 
retired at the age of 85. 
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Benefits can include:
n Supporting scholarships, professorships, research,  
and programs that are important to you
n Reducing estate taxes
n Retaining control of assets during your lifetime
To learn how you can make a planned gift,  
contact the Oce of Planned Giving:
(800) 835-3503 or (314) 935-5373
plannedgiving.wustl.edu
Leading together, the Washington University 
community defines the forefront of medical innovation 
— advancing human health, preparing tomorrow’s 
leaders, and enriching the quality of life. A simple yet 
significant way to support these eorts is by making  
a planned gift through your will, trust, life insurance,  
IRA, or qualified retirement plan. 
Together, we can change lives!
For information on supporting the School of Medicine 
through an outright gift, contact:
Pamela Buell, Associate Vice Chancellor for  
Medical Alumni and Development 
(314) 935-9691    email: meddev@wustl.edu 
  Consult with your legal or tax advisor before making a charitable gift.
Poster session in the Farrell Learning and Teaching Center.
 Together
advancing health
transforming lives
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The wonder of it all
This early 17th century book illustration 
of the cosmos integrated ancient 
mystical beliefs with contemporary 
scientific concepts. Its author, Oxford 
physician Robert Fludd, advocated for 
alchemy as the basis of new medicine, 
whereas Johannes Kepler regarded math 
as the only proper basis for natural 
science; a publishing battle ensued.  
A recent exhibit in the Bernard Becker 
Medical Library, Occultism and Science in 
the Early Modern World, displayed several 
other examples from this transitional era 
in the history of science, when natural 
and supernatural were understood along 
a continuum. However, observation — 
and calculation — later became the 
prime mechanisms of scientific progress.
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